Dr. George A. Fisher
Claim this profileStanford Cancer Institute Palo Alto
Studies Colorectal Cancer
Studies Adenocarcinoma
5 reported clinical trials
16 drugs studied
Area of expertise
1Colorectal Cancer
Stage III
Stage IV
dMMR negative
2Adenocarcinoma
Stage IV
dMMR negative
MSI-H negative
Affiliated Hospitals
Clinical Trials George A. Fisher is currently running
VGT-309 Imaging Technique
for Colorectal Cancer
This trial is testing a new substance called VGT-309 that helps doctors see colorectal tumors better during an endoscopy by making them glow under a special light. It targets patients with colorectal tumors to improve detection. The study also looks at various biomarkers in tumor samples.
Recruiting1 award Phase < 114 criteria
Reduced-Intensity Chemoradiation
for Anal Cancer
This phase II trial studies how well lower-dose chemotherapy plus radiation (chemoradiation) therapy works in comparison to standard-dose chemoradiation in treating patients with early-stage anal cancer. Drugs used in chemotherapy, such as mitomycin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Giving chemotherapy with radiation therapy may kill more tumor cells. This study may help doctors find out if lower-dose chemoradiation is as effective and has fewer side effects than standard-dose chemoradiation, which is the usual approach for treatment of this cancer type.
Recruiting3 awards Phase 25 criteria
More about George A. Fisher
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments George A. Fisher has experience with
- Fluorouracil
- Gemcitabine
- Nab-paclitaxel
- Ipilimumab
- Nivolumab
- VGT-309
Breakdown of trials George A. Fisher has run
Colorectal Cancer
Adenocarcinoma
Pancreatic Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does George A. Fisher specialize in?
George A. Fisher focuses on Colorectal Cancer and Adenocarcinoma. In particular, much of their work with Colorectal Cancer has involved Stage III patients, or patients who are Stage IV.
Is George A. Fisher currently recruiting for clinical trials?
Yes, George A. Fisher is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that George A. Fisher has studied deeply?
Yes, George A. Fisher has studied treatments such as Fluorouracil, Gemcitabine, Nab-paclitaxel.
What is the best way to schedule an appointment with George A. Fisher?
Apply for one of the trials that George A. Fisher is conducting.
What is the office address of George A. Fisher?
The office of George A. Fisher is located at: Stanford Cancer Institute Palo Alto, Palo Alto, California 94304 United States. This is the address for their practice at the Stanford Cancer Institute Palo Alto.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.